Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A0A3Q8IU86
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 110 | 114 | PF00656 | 0.754 |
CLV_NRD_NRD_1 | 107 | 109 | PF00675 | 0.709 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.419 |
CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.694 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.623 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.350 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.285 |
CLV_PCSK_PC1ET2_1 | 74 | 76 | PF00082 | 0.422 |
CLV_PCSK_PC1ET2_1 | 88 | 90 | PF00082 | 0.241 |
CLV_PCSK_SKI1_1 | 45 | 49 | PF00082 | 0.355 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.447 |
CLV_PCSK_SKI1_1 | 98 | 102 | PF00082 | 0.498 |
DEG_APCC_DBOX_1 | 44 | 52 | PF00400 | 0.355 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.609 |
DOC_CYCLIN_RxL_1 | 95 | 105 | PF00134 | 0.600 |
DOC_MAPK_gen_1 | 88 | 96 | PF00069 | 0.453 |
DOC_PP1_RVXF_1 | 59 | 66 | PF00149 | 0.447 |
DOC_USP7_MATH_1 | 145 | 149 | PF00917 | 0.689 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.734 |
LIG_deltaCOP1_diTrp_1 | 120 | 126 | PF00928 | 0.600 |
LIG_FHA_1 | 155 | 161 | PF00498 | 0.594 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.408 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.752 |
LIG_FHA_2 | 119 | 125 | PF00498 | 0.469 |
LIG_LIR_Gen_1 | 120 | 129 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 120 | 126 | PF02991 | 0.517 |
LIG_LIR_Nem_3 | 29 | 33 | PF02991 | 0.470 |
LIG_NRP_CendR_1 | 163 | 166 | PF00754 | 0.669 |
LIG_SH2_STAP1 | 140 | 144 | PF00017 | 0.702 |
LIG_SH2_STAT3 | 151 | 154 | PF00017 | 0.622 |
LIG_SH2_STAT3 | 35 | 38 | PF00017 | 0.527 |
LIG_SH2_STAT5 | 151 | 154 | PF00017 | 0.646 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.438 |
LIG_WRC_WIRS_1 | 27 | 32 | PF05994 | 0.475 |
MOD_CDK_SPK_2 | 6 | 11 | PF00069 | 0.656 |
MOD_CK1_1 | 118 | 124 | PF00069 | 0.634 |
MOD_CK1_1 | 147 | 153 | PF00069 | 0.689 |
MOD_CK1_1 | 29 | 35 | PF00069 | 0.552 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.566 |
MOD_GlcNHglycan | 147 | 150 | PF01048 | 0.692 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.388 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.615 |
MOD_GSK3_1 | 150 | 157 | PF00069 | 0.637 |
MOD_NEK2_2 | 37 | 42 | PF00069 | 0.495 |
MOD_PIKK_1 | 150 | 156 | PF00454 | 0.623 |
MOD_PKA_1 | 107 | 113 | PF00069 | 0.700 |
MOD_PKA_2 | 107 | 113 | PF00069 | 0.700 |
MOD_Plk_1 | 140 | 146 | PF00069 | 0.704 |
MOD_Plk_4 | 118 | 124 | PF00069 | 0.618 |
MOD_Plk_4 | 147 | 153 | PF00069 | 0.691 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.422 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.735 |
MOD_SUMO_rev_2 | 58 | 63 | PF00179 | 0.480 |
TRG_DiLeu_BaEn_1 | 59 | 64 | PF01217 | 0.355 |
TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.330 |
TRG_ER_diArg_1 | 106 | 108 | PF00400 | 0.603 |
TRG_ER_diArg_1 | 163 | 166 | PF00400 | 0.670 |
TRG_ER_diArg_1 | 65 | 68 | PF00400 | 0.350 |
TRG_Pf-PMV_PEXEL_1 | 98 | 102 | PF00026 | 0.522 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZD1 | Leptomonas seymouri | 80% | 99% |
A0A0S4JQG9 | Bodo saltans | 45% | 92% |
A0A1X0NRJ6 | Trypanosomatidae | 61% | 100% |
A0A422N9P9 | Trypanosoma rangeli | 59% | 100% |
A4HLY2 | Leishmania braziliensis | 88% | 100% |
A4I9B1 | Leishmania infantum | 99% | 100% |
C9ZJB5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 62% | 100% |
E9B4B1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |
Q4Q3R5 | Leishmania major | 98% | 100% |